Background {#Sec1}
==========

Recent epidemiological studies have shown that the prevalence of high blood pressure or hypertension has significantly increased among children and adolescents worldwide \[[@CR1]--[@CR3]\]. Hypertension is one of the major cardiovascular risk factors and is associated with cardiovascular mortality, and cardiovascular diseases are the main cause of death in Lithuania \[[@CR4], [@CR5]\]. In Lithuania, the prevalence of increased BP or hypertension in children and adolescents is 21% \[[@CR6]\] and 35% \[[@CR3]\], respectively. In the adult population, approximately 60% of men and 45% of women aged 25--64 years have elevated BP \[[@CR7]\]. High blood pressure in childhood commonly leads to hypertension in adulthood \[[@CR8]--[@CR10]\], which is the leading cause of premature death worldwide \[[@CR11]\]. Hypertension in children can lead to left ventricular hypertrophy and pathologic vascular changes \[[@CR12], [@CR13]\].

Studies support the fact that hypertension is a complex disease resulting from the interactions of genes and environmental factors \[[@CR14]\]. Epidemiological studies suggest that genetic factors account for approximately 30% of the variation in blood pressure \[[@CR15]--[@CR17]\]. Studies have demonstrated that hypertension is twice as common in subjects who have one or two hypertensive parents \[[@CR18], [@CR19]\]. Twin studies have also shown that genes could explain approximately 50% of blood pressure variation \[[@CR20]\].

The renin-angiotensin-aldosterone system (RAAS) is a major regulator of arterial pressure and as an important endocrine and paracrine system plays a key role in the pathogenesis of essential hypertension \[[@CR21]\]. Investigations have shown that the genetic variations of the RAAS-encoding genes have strong connections with the genetic basis of essential hypertension and antihypertensive treatment \[[@CR22]\]. An increased risk of hypertension has been associated with angiotensinogen (*AGT*), angiotensin-converting enzyme (*ACE*), and angiotensin II receptor 1 (*AGTR1*). Angiotensinogen is a protein secreted by the liver and found in the α2- globulin fraction of plasma. The enzyme renin cleaves AGT forming angiotensin I, and ACE or kinase II as dipeptidyl carboxypeptidase encoded by the *ACE* gene produces the active hormone angiotensin II that promotes vasoconstriction. The M235 T (methionine substituted by threonine) polymorphism in the *AGT* gene was associated with hypertension in Caucasians and with a 10--20% increase in plasma angiotensinogen levels in individuals homozygous for the T allele \[[@CR23]\]. ACE plays an important role in blood pressure regulation and electrolyte balance by hydrolyzing angiotensin I into angiotensin II. ACE is not only a membrane-bound enzyme on the surface of the vascular endothelial cells, but it also circulates in blood plasma \[[@CR24]\]. The *ACE* insertion/deletion (I/D) polymorphism is associated with the concentration of the circulating enzyme. Individuals homozygous for the D allele have higher tissue and plasma ACE concentrations than heterozygotes and II homozygotes do \[[@CR25]\]. Angiotensin 2 receptor type 1 encoded by *AGTR1* gene mediates the major cardiovascular effects of angiotensin II, leading to such effects as vasoconstriction, increased arterial blood pressure, and myocardial contractility \[[@CR26]\]. Studies have shown that A/C transversion at position 1166 in the 3′ untranslated region of the *AGTR1* gene could be associated with hypertension \[[@CR27]--[@CR29]\].

Although relationships between overweight and obesity with prehypertension and hypertension have been established \[[@CR3]\], the association between polymorphisms in RAS genes and HBP among Lithuanian schoolchildren based on obesity-related traits has not been studied yet.

The aim of the present cross-sectional study was to investigate if polymorphisms of the RAS genes *AGT, AGTR1,* and *ACE* might be associated with an increased risk for higher blood pressure and hypertension in the Lithuanian children population.

Methods {#Sec2}
=======

Study design and population {#Sec3}
---------------------------

This cross-sectional study included a randomly selected sample of 709 subjects aged 12--15 years, who had participated in the baseline survey of "Prevalence and risk factors of high blood pressure in 12--15-year-old Lithuanian children and adolescents (Study 1, 2010-2012)" in Kaunas city and Kaunas district, located in Kaunas County, Lithuania \[[@CR3]\]. The school children who had congenital heart defects, kidney diseases, or endocrine diseases were excluded from the study.

The sample size was estimated using the formula n = z^2^pq/d^2^, where: n -- sample size, z = 1.96 at the 95% confidence level, *p* = 0.35 (the prevalence of HBP was 35% among Lithuanian adolescents aged 12--15 years \[[@CR3]\]), q = 1--p and d = 0.05 (the degree of precision). The minimum sample size was calculated to be 350 participants.

Measurements {#Sec4}
------------

Blood pressure and anthropometric measurements (weight, height, and waist circumference (WC)) performed in this study have been presented in our previous publication \[[@CR3]\].

### Blood pressure measurement {#Sec5}

BP measurements were performed with an automatic BP monitor using a cuff of an appropriate size. The average of three BP measurements was calculated and used in the analysis, according to "The 4^th^ Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents" (National High Blood Pressure Education Program (NHBPEP) Working Group on High Blood Pressure in Children and Adolescents) \[[@CR30]\]. High BP was defined as systolic blood pressure (SBP) and diastolic blood pressure (DBP) ≥90th percentile.

### Anthropometric measurement {#Sec6}

All subjects underwent anthropometric measurements. According to the cut-off points of the BMI for children and adolescents proposed by the International Obesity Task Force (IOTF) \[[@CR31]\], the subjects were grouped into three categories: normal-weight, overweight, and obese. Using the cut-off values of the percentiles of the WC according to the criteria of the Third National Health and Nutrition Examination Survey (NHANES III) \[[@CR32]\], the participants were classified into three groups on the basis of their WC: below the 75th percentile, 75th \< 90th percentile, and ≥90th percentile. High waist value was defined as WC ≥75th percentile.

Genetic analysis {#Sec7}
----------------

For DNA extraction, saliva samples were collected into tubes from each individual. Genomic DNA was extracted using a commercial DNA isolation kit - "Genomic DNA Purification Kit" ("Thermo Fisher Scientific", Lithuania) according to the manufacturer's instructions. Aliquots of purified DNA were stored at −20 °C until use in genetic analysis.

Subjects were genotyped for *AGT* (M235 T, rs699) and *AGTR1* (A1166C, rs5186) gene polymorphisms with TaqMan allelic discrimination Assay-By-Design genotyping kits: C_1985481_20 and C_3187716_10, respectively (Applied Biosystems, Foster City, CA, USA).

To analyze *ACE* (ID, rs4340) polymorphism, genomic DNA was amplified by PCR reaction with primers 5′-AGGAGAGGAGAGAGACTCAAGCACG-3′ and 5′-GGCAGC CTGGTTGATGAGTTCC-3′ \[[@CR33]\]. PCR was performed in a 25-μL volume containing approximately 50 ng of the genomic template, 0.4 μmol/L of each primers, 200 μmol/L of each deoxynucleotide triphosphate (dNTP) (Termofisher, Lithuania), 1 unit of Maxima Hot Start *Taq* polymerase (Termofisher, Lithuania), 2 mmol/L of MgCl~2~ (Termofisher, Lithuania), and 1X Maxima Hot Start PCR Buffer (Termofisher, Lithuania). Cycling conditions were preceded by a denaturing step at 95 °C for 10 min, followed by 32 cycles of denaturation at 94 °C for 30 s, annealing at 68.8 °C for 30 s, and synthesis at 72 °C for 1 min and then at 59 °C for 1 min. The reaction was ended by incubation at 72 °C for 10 min. PCR products were separated by electrophoresis (100 V for 1.5 h; 1.5% agarose gel) and visualized by ethidium bromide-stained agarose gel under ultraviolet light using a video documentation system, the BioDocAnalyse 2.0 (Biometra, Göttingen, Germany). The I allele of *ACE* manifested as a 700 bp band, and the D allele was seen as a 400 bp band of DNA. Each *ACE* DD genotype was confirmed through a second PCR with primers specific for the insertion sequence as previously described \[[@CR33]\].

DNA sequencing for different *AGT*, *AGTR1,* and *ACE* gene genotypes was used for quality control.

Statistical analysis {#Sec8}
--------------------

Continuous variables were expressed as mean ± standard deviation (SD). The normality of the distribution of continuous variables was assessed by the Kolmogorov-Smirnov test. Comparisons between the groups were performed by applying the chi-square (χ^2^) test and Student's t-test. The χ^2^ test was used for the assessment of the Hardy-Weinberg equilibrium (HWE) for the distribution of genotypes. Logistic regression analyses were used to test for the associations of *AGT*, *AGTR1,* and *ACE* polymorphisms with HBP under inheritance models to calculate the odds ratios (ORs, 95% CI) for *AGT, AGTR1,* and *ACE* polymorphism. ORs were adjusted for BMI and WC. The Mantel-Haenszel technique was used to estimate the associations of *AGT*, *AGTR1,* and *ACE* polymorphisms with HBP while controlling for BMI and WC separately. The data were analyzed separately for boys and girls.

Results {#Sec9}
=======

The characteristics of the study subjects according to BP levels are presented in Table [1](#Tab1){ref-type="table"}. Among 709 study subjects aged 12--15 years (mean ± SD age: 13.27 ± 1.14 years), 49.8% (*n* = 353) were boys and 50.2% (*n* = 356) were girls. There was no significant difference in the mean age between these groups.Table 1Characteristics of the study population according to the BP levelCharacteristicsHBP (*n* = 274)NBP (*n* = 435)*P* valueAge, years, mean (SD)13.30 (1.13)13.26 (1.15)0.647SBP, mm Hg, mean (SD)137.03 (10.89)110.94 (7.35)\<0.001DBP, mm Hg, mean (SD)70.17 (8.20)62.25 (6.59)\<0.001BMI, kg/m^2^, mean (SD)21.31 (3.54)18.68 (2.81)\<0.001WC, cm, mean (SD)72.27 (9.05)64.58 (6.89)\<0.001Weight, kg, mean (SD)58.71 (12.41)49.26 (10.77)\<0.001Height, cm, mean (SD)165.48 (8.82)161.67 (9.65)\<0.001Sex, n (%) Boys169 (47.9)184 (52.1)\<0.001 Girls105 (29.5)251 (70.5)Age, years, n (%) 12--13156 (36.9)267 (63.1)0.240 14--15118 (41.3)168 (58.7)BMI categories, n (%) Normal weight195 (33.0)396 (67.0)\<0.001 Overweight58 (62.4)35 (37.6) Obesity21 (84.0)4 (16.0)WC percentile categories, n (%)  \< 75th204 (33.2)411 (66.8)\<0.001 75th--\<90th48 (69.6)21 (30.4)  ≥ 90th21 (87.5)3 (12.5)The means were compared using the *t* testCategorical variables were compared using the chi-square (χ^2^) test*Abbreviations*: *NBP* normal blood pressure, *HBP* high blood pressure, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *BMI* body mass index, *WC* waist circumference, *SD* standard deviation

The overall prevalence of HBP was 38.6% in the entire study sample. HBP was more frequently detected in boys than in girls (47.9% vs. 29.5%; *p* \< 0.001). Boys aged 14 to 15 years were more likely to have HBP than boys aged 12 to 13 years (56.8% vs. 41.5%; *p* = 0.005). Higher mean values of SBP and WC were detected in boys with HBP (SBP: 139.47 mmHg; WC: 73.21 cm) than in girls with HBP (SBP: 133.11 mmHg; WC: 70.77 cm), p \< 0.001 and *p* = 0.024, respectively (data not shown). Boys with HBP had significantly higher SBP. The participants with HBP had significantly higher mean values of BMI, WC, weight, and height, compared to normotensive participants. Overweight, obesity, and high WC (**≥**75th percentile) were much more common in subjects with HBP than in the normal blood pressure (NBP) group for both sexes separately.

Allele and genotype frequencies in HBP and NBP groups were in the Hardy-Weinberg equilibrium (*p* \> 0.05) (Table [2](#Tab2){ref-type="table"}). No significant differences in the frequency of the *AGT* or *AGTR1* genotypes or alleles were observed between normotensive subjects and those with HBP according to sex, except for *ACE* genotypes in boys (*p* = 0.021).Table 2Distribution of the *AGT, AGTR1,* and *ACE* genotypes and the frequency of alleles in the study populationCharacteristicsBoysGirlsHBPNBPHBPNBP*AGT*, M235 T genotypes, n (%) MM45 (27.3)49 (27.1)28 (27.2)65 (26.7) MT82 (49.7)77 (42.5)57 (55.3)125 (51.2) TT38 (23.0)55 (30.4)18 (17.5)54 (22.1)χ^2^ = 2.70, *p* = 0.259χ^2^ = 0.99, *p* = 0.607*AGT*, M235 T alleles, frequency M0.520.480.550.52 T0.480.520.450.48χ^2^ = 0.99, *p* = 0.321χ^2^ = 0.39, *p* = 0.531*AGTR1*, A1166C genotypes, n (%) AA87 (52.4)85 (47.2)59 (56.2)123 (50.2) AC67 (40.4)77 (42.8)39 (37.1)107 (43.7) CC12 (7.2)18 (10.0)7 (6.7)15 (6.1)χ^2^ = 1.35, *p* = 0.508χ^2^ = 1.29, *p* = 0.524*AGTR1*, A1166C alleles, frequency A0.730.690.750.72 C0.270.310.250.28χ^2^ = 1.32, *p* = 0.251χ^2^ = 0.55, *p* = 0.450*ACE*, ID genotypes, n (%) II34 (20.6)58 (31.6)25 (24.0)65 (26.4) ID94 (57.0)79 (42.9)55 (52.9)126 (51.2) DD37 (22.4)47 (25.5)24 (23.1)55 (22.4)χ^2^ = 7.74, p = 0.021χ^2^ = 0.22, *p* = 0.897*ACE,* ID alleles, frequency I0.490.530.500.52 D0.510.470.500.48χ^2^ = 1.06, *p* = 0.304χ^2^ = 0.14, *p* = 0.707Comparisons between groups were performed by applying the χ^2^ test*Abbreviations*: *NBP* normal blood pressure, *HBP* high blood pressure, *AGT* angiotensinogen, *AGTR1* angiotensin II receptor 1, *ACE* angiotensin-converting enzyme

Although obesity-related traits such as BMI and WC did not differ according to *AGT*, *AGTR1,* or *ACE* genotypes between HBP and NBP subjects, overweight combined with obesity were much more common in boys with the *ACE* ID + DD genotype compared to *ACE* II carriers with high SBP (*p* = 0.04) (data not shown).

The mean SBP and DBP levels of the participants according to genotypes are shown in Table [3](#Tab3){ref-type="table"}. The mean values of SBP were significantly higher in boys with HBP and the *ACE* ID and *AGTR1* AC genotypes compared to the *ACE* II and *AGTR1* AA carriers. No association was observed in the group of girls.Table 3Distribution of *AGT* M235 T, *AGTR1* A1166C, and *ACE* ID genotypes according to systolic and diastolic blood pressure in the study populationCharacteristicsHBPNBPSBP (mmHg)DBP (mmHg)SBP (mmHg)DBP (mmHg)Boys*AGT*, M235 T genotypes, mean (SD) MM139.56 (10.69)68.35 (8.16)112.57 (6.62)62.65 (7.61) MT138.72 (10.92)69.07 (8.47)111.65 (8.50)61.03 (7.25) TT139.32 (11.94)67.11 (7.04)109.71 (7.68)61.41 (6.47)*AGTR1*, A1166C genotypes, mean (SD) AA138.30 (9.82)69.15 (7.98)109.87 (7.95)61.25 (7.23) AC139.77 (11.76)^a^67.82 (8.18)112.74 (7.58)62.11 (7.24) CC141.11 (14.54)66.19 (7.29)111.15 (7.34)61.59 (5.62)*ACE*, ID genotypes, mean (SD) II135.33 (8.22)68.55 (7.69)110.96 (7.39)62.45 (8.03) ID139.90 (12.28)^b^68.55 (8.33)110.38 (8.71)60.87 (6.74) DD140.21 (8.99)67.65 (7.65)112.56 (7.05)61.40 (6.95)Girls*AGT*, M235 T genotypes, mean (SD) MM133.20 (10.21)73.64 (8.43)111.38 (7.27)63.73 (5.19) MT133.26 (9.31)73.16 (7.11)110.60 (6.31)62.24 (6.22) TT131.56 (6.06)70.72 (8.63)110.08 (8.10)62.96 (6.70)*AGTR1*, A1166C genotypes, mean (SD) AA133.49 (9.62)72.13 (7.36)110.31 (6.86)63.09 (6.38) AC133.44 (8.59)74.21 (7.87)111.03 (7.35)62.49 (5.98) CC128.00 (5.47)71.95 (9.77)111.44 (4.78)62.62 (4.14)*ACE*, ID genotypes, mean (SD) II132.72 (7.49)71.89 (7.55)111.45 (7.88)62.69 (7.01) ID133.39 (9.47)72.42 (7.29)110.83 (6.25)62.75 (5.36) DD132.49 (9.89)74.54 (8.65)109.58 (7.30)62.97 (6.51)*Abbreviations*: *NBP* normal blood pressure, *HBP* high blood pressure, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *AGT* angiotensinogen, *AGTR1* angiotensin II receptor 1, *ACE* angiotensin-converting enzyme^a^ *p* \< 0.05 between *AGTR1* AC vs. *AGTR1* AA in boys with HBP (*t* test)^b^ *p* \< 0.05 between *ACE* ID vs. *ACE* II in boys with HBP (*t* test)

The results of multivariate logistic regression analyses are presented in Table [4](#Tab4){ref-type="table"}. To examine sex-specific associations with HBP, we calculated adjusted odds ratios by BMI and WC for boys and girls separately. No significant association between *AGT* and *AGTR1* genotypes and HBP was found in either boys or girls.Table 4Associations of AGT, AGTR1, and ACE polymorphisms with high blood pressure by sex (multivariate analysis)BoysGirlsModelGenotypesaOR^a^ (95% CI)*P* valueaOR^a^ (95% CI)*P* valueAGTCo-dominantMM1.001.00MT1.20 (0.70--2.03)0.5091.03 (0.58--1.84)0.926TT0.72 (0.39--1.33)0.2960.72 (0.34--1.54)0.400DominantMM1.001.00MT + TT0.99 (0.61--1.64)0.9940.94 (0.54--1.63)0.817RecessiveMM + MT1.001.00TT0.65 (0.39--1.07)0.0910.71 (0.37--1.36)0.301Additive0.85 (0.63--1.15)0.3040.87 (0.60--1.25)0.448AGTR1Co-dominantAA1.001.00AC0.84 (0.53--1.33)0.4510.99 (0.59--1.68)0.986CC0.66 (0.29--1.48)0.3091.21 (0.44--3.33)0.771DominantAA1.001.00AC + CC0.80 (0.52--1.24)0.3231.02 (0.62--1.69)0.929RecessiveAA + AC1.001.00CC0.71 (0.32--1.56)0.3911.21 (0.45--3.25)0.700Additive0.82 (0.58--1.15)0.2561.05 (0.70--1.57)0.821ACECo-dominantII1.001.00ID**2.05 (1.19--3.53)**0.0100.92 (0.51--1.67)0.793DD1.43 (0.76--2.69)0.2260.89 (0.44--1.82)0.749DominantII1.001.00ID + DD**1.82 (1.09--3.04)**0.0220.91 (0.52--1.60)0.752RecessiveII + ID1.001.00DD0.89 (0.53--1.48)0.6460.94 (0.52--1.70)0.834Additive1.20 (0.88--1.63)0.2530.94 (0.66--1.35)0.745*Abbreviations*: *AGT* angiotensinogen, *AGTR1* angiotensin II receptor 1, *ACE* angiotensin-converting enzyme, *aOR* adjusted odds ratio, *CI* confidence intervals^a^adjusted for the body mass index and waist circumference

The results showed that boys who carried the *ACE* ID genotype and the *ACE* ID + DD genotypes had higher odds of having HBP than carriers of the *ACE* II genotype did (in the co-dominant model, aOR = 2.05; *p* = 0.01, and in the dominant model, aOR = 1.82; *p* = 0.022, respectively).

Boys who carried the *ACE* ID + DD genotypes had higher odds of having HBP than carriers of the *ACE* II genotype did (controlling for BMI: OR~MH~ = 1.83; 95% CI, 1.11--3.02, *p* = 0.024; and controlling for WC: OR~MH~ = 1.76; 95% CI, 1.07--2.92, *p* = 0.035). These associations were not significant among girls (data not shown).

Discussion {#Sec10}
==========

To our knowledge, this is the first cross-sectional study investigating the association between polymorphisms in RAS genes and hypertension among 12--15 year-old Lithuanian schoolchildren based on obesity-related traits.

Studies on elevated blood pressure or hypertension among children and adolescents showed that the prevalence rates varied widely \[[@CR34]--[@CR36]\]. According to our data, the prevalence of high blood pressure was 38.6%, and was more frequently detected in boys than in girls.

The prevalence of overweight is high among children across Europe, with an especially worrisome prevalence in Southern European countries \[[@CR37]\]*.* A study in Lithuania showed that the prevalence of overweight and obesity among 7--17 year-old children and adolescents was 12.6% and 4.1%, respectively, with a higher prevalence among boys \[[@CR38]\]. The prevalence of overweight and obesity in our study on 12--15 year-old children was similar (13.1% and 3.5%, respectively), but was inconsistent with the results of other studies conducted in the Czech Republic \[[@CR39]\] and in Spain \[[@CR40]\], which reported higher prevalence rates of overweight or obesity. As compared to the data published in other countries, Lithuania still has the lowest prevalence of overweight and obesity among 7--17 year-old children and adolescents in Europe, being similar to Poland \[[@CR41]\] and Latvia \[[@CR37]\] in this respect. The present study and other epidemiological studies indicate that the prevalence of HBP is higher among overweight and obese children compared to children with normal weight \[[@CR42], [@CR43]\]. Studies have shown that overweight, obesity, and high waist circumference were significantly associated with hypertension or HBP (≥90th percentile) among children and adolescents \[[@CR44]--[@CR46]\]. Patients with HBP had significantly higher mean values of the body mass index and waist circumference compared to normotensive children for both sexes separately. Higher systolic blood pressure and waist circumference were more commonly observed in boys than in girls.

The RAS system includes multiple components and plays a key role in BP regulation \[[@CR21]\]. The enzyme renin cleaves the substrate AGT to produce angiotensin I (Ang I). Ang I is converted to Ang II by ACE, an enzyme present on the cell surface of many cells, mainly on vascular endothelial cells. Ang II stimulates renal sodium reabsorption and vasoconstriction, and thus raises blood pressure. Most of hypertensinogenic actions of Ang II go through specific angiotensin-receptors such as AGTR1. AGTR2 receptors promote vasodilatation, cell differentiation, and the inhibition of cell growth and apoptosis \[[@CR22]\]. Mutations in the genes of the RAS components might be associated with the pathogenesis of hypertension. The Jeunemaitre group was the first to report the linkage of the molecular variants M235 T with hypertension in Caucasians \[[@CR23]\]. The 235 T allele of the *AGT* gene was shown to be linked to an increased level of circulating angiotensinogen \[[@CR23], [@CR47], [@CR48]\]. The level of circulating ACE depends on *ACE* gene (I/D) polymorphism. Persons with the D allele have higher plasma ACE levels and higher rates of hypertension, compared to carriers with the I allele \[[@CR23], [@CR25]\]. Studies found that subjects with the ID and DD genotype of the *ACE* I/D gene polymorphism had a higher increase in both pulse and SBP when compared to subjects with the II genotype \[[@CR49]\].

In our study, the frequencies of *AGT*, *AGTR1,* and *ACE* genotypes and alleles were similar to those reported in other Caucasian populations \[[@CR50], [@CR51]\]. According to multivariate logistic regression analysis of our data, the present study failed to demonstrate that *AGT* M235 T or *AGTR1* A1166C polymorphisms had any association with hypertension among either boys or girls, except for the *ACE* ID polymorphism. An insertion/deletion (I/D) polymorphism of 287 base pairs is one of the most intensively investigated polymorphisms in the field of research on hypertension and cardiovascular diseases \[[@CR19], [@CR25], [@CR52]\]. The present study identified a sex-specific variant in the *ACE* gene and its link to elevated blood pressure. We found significant evidence of an association between the *ACE* ID genotype and elevated systolic blood pressure in boys, but not in girls. Increased odds for hypertension in the boys' population were higher with *ACE* ID + DD than with *ACE* II genotypes. In boys, the dominant model of the *ACE* gene even after adjustment for the body mass index and waist circumference (ID + DD versus II) showed that D allele carriers were by 1.82 times more likely to be hypertensive than carriers of the II genotype. Our results are generally consistent with the majority of other studies conducted in child and adult populations \[[@CR9], [@CR51], [@CR53]--[@CR55]\]. The mechanism of the sex-specific association with high blood pressure or hypertension remains unclear. There is an opinion that estrogens could play a protective role against hypertension by regulating the RAS, mainly through the angiotensin-converting enzyme 2/Ang(1--7)/Mas receptor (MasR) and AT~2~R pathways \[[@CR56], [@CR57]\].

The polymorphism A1166C in the 3′ untranslated region of the *AGTR1* gene was detected in a study by Bonnardeaux et al. (1994) who also identified its association with hypertension \[[@CR58]\]. Several recent findings and a meta-analysis have shown that it is associated with essential hypertension \[[@CR59], [@CR60]\]; however, other studies failed to reproduce such results \[[@CR9], [@CR50], [@CR61]\]. Although we observed that boys with *AGTR1* AC genotype had significantly higher SBP compared to AA carriers, and SBP was much higher among boys with *AGTR1* CC genotype, but the differences did not reach statistical significance due to the small number of homozygotes.

The current study has several limitations. In the present study, BP readings were obtained by using an automatic oscillometric monitor that has been clinically validated. This study investigated only the population of 12--15-year-old adolescents of the second largest city and district of Lithuania. Lithuania is characterized by stable and homogenous ethnic structure of the population \[[@CR62]\]. According to the 2011 Lithuanian Population Census, Lithuanians made up about 94.4% of the population in Kaunas County (84% in Lithuania) \[[@CR63]\]. The study subjects were randomly selected, so study sample included mostly ethnic Lithuanians.

Furthermore, selection bias, information bias, and confounding factors may affect the results of an observational study \[[@CR64]\]. Therefore, further studies are needed to examine a larger population of younger children and older adolescents. There are no measurements of plasma ACE or AGT levels available to correlate directly with the genetic polymorphisms investigated in this study. Pubertal status and biochemical parameters were not evaluated in our study.

Conclusions {#Sec11}
===========

We found that the D allele of the ID polymorphism in the *ACE* gene was significantly associated with hypertension and with obesity-related traits in boys, but not in girls. The evaluated polymorphisms of the *AGT* and *AGTR1* genes did not contribute to the presence of HBP in the present study and may be seen as predisposing factors.
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